Persistent Efficacy of Dextromethorphan (DM)/Quinidine (Q) for Pseudobulbar Affect (PBA): Results from a 12-Week, Open-Label Extension (OLE) Study

被引：0
|
作者：
Pioro, Erik
Brooks, Benjamin
Cummings, Jeffrey
Schiffer, Randolph
Wynn, Daniel
Hepner, Adrian
Kaye, Randall
机构：
来源：
NEUROLOGY | 2010年 / 75卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：380 / 380
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of etanercept treatment in children and adolescents with plaque psoriasis: 96-week results of open-label extension study
    Paller, Amy
    Pariser, David
    Siegfried, Elaine
    Kricorian, Gregory
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB11 - AB11
  • [42] 52-week laboratory safety findings from an open-label extension (OLE) study of dupilumab in adolescent patients with atopic dermatitis (LIBERTY AD PED-OLE)
    Cork, Michael J.
    Lockshin, Benjamin
    Blauvelt, Andrew
    Chen, Zhen
    Khokhar, Faisal A.
    Bansal, Ashish
    Prescilla, Randy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB120 - AB120
  • [43] Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension
    Lipton, Richard B.
    Tepper, Stewart J.
    Silberstein, Stephen D.
    Kudrow, David
    Ashina, Messoud
    Reuter, Uwe
    Dodick, David W.
    Zhang, Feng
    Rippon, Gregory A.
    Cheng, Sunfa
    Mikol, Daniel D.
    CEPHALALGIA, 2021, 41 (01) : 6 - 16
  • [44] PRISM II: An Open-Label Study to Assess the Safety, Tolerability, and Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Results from the Alzheimer's Disease/Dementia Cohort
    Doody, Rachelle S.
    D'Amico, Stephen
    Cutler, Andrew J.
    Shin, Paul
    Ledon, Frederic
    Yonan, Charles
    Siffert, Joao
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 23 (03): : S163 - S164
  • [45] Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, open-label study in stable patients switched from typical and atypical oral antipsychotics
    Cetin, M
    Ebrinc, S
    Basoglu, C
    Semiz, UB
    Gunay, H
    Iyisoy, MS
    Ergun, BM
    Gunes, C
    Sahan, A
    Oguz, M
    Noyan, O
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S134 - S135
  • [46] Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: A 12-week randomized controlled clinical trial with a 52-week open-label extension
    Reiff, A
    Lovell, DJ
    van Adelsberg, J
    Kiss, MHB
    Goodman, S
    Zavaler, MF
    Chen, PY
    Bolognese, JA
    Cavanaugh, PF
    Reicin, AS
    Giannini, EH
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (05) : 985 - 995
  • [47] EFFECTIVENESS OF DIFFERENT SCHEMES OF ETORICOXIB ADMINISTRATION IN REDUCTION OF ACTIVE SACROILIITIS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS - RESULTS OF A 12-WEEK, PROSPECTIVE, OPEN-LABEL STUDY
    Gaydukova, I.
    Rebrov, A. P.
    Akulova, A. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 282 - 282
  • [48] Safety and Efficacy of Lenabasum at Week 68 in an Open-Label Extension of a Phase 2 Study of Lenabasum in Refractory Skin-Predominant Dermatomyositis (DM) Subjects
    Werth, Victoria
    Pearson, David
    Okawa, Joyce
    Feng, Rui
    Concha, Josef
    Patel, Basil
    Hejazi, Emily
    Constantine, Scott
    Dgetluck, Nancy
    White, Barbara
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] Transdermal lisuride in patients with idiopathic restless legs syndrome: Results from a placebo-controlled, double-blind 12-week dose-finding study with a 48-week open-label extension phase
    Beres, H.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S76 - S76
  • [50] Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12-week Placebo-controlled Dose-finding Study with a 42-week Open-label Extension
    Takeda, Masayuki
    Nishizawa, Osamu
    Imaoka, Takeshi
    Morisaki, Yoji
    Viktrup, Lars
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2012, 4 (03) : 110 - 119
12345